NEW YORK (GenomeWeb News) – Mutations in an obesity-associated gene called FTO can contribute to melanoma risk through a pathway that appears independent of body mass index, according to a Nature Genetics article by members of an international melanoma consortium known as GenoMEL. With the help of imputed genotype information, the group conducted a multi-phase association study starting with nearly 1,400 European or Israeli individuals with melanoma and more than 3,500 unaffected controls from Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.